HIV prevention programs aimed at women are cost-effective.
D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D006266:Health Education / Q000191:economics* / Q000379:methods; D006801:Humans; D016730:Program Development / Q000191:economics*; D014481:United States